New test dissolves threat of fake drugs
Fake news can be tricky to spot, but spotting fake drugs just got a little easier. Researchers have devised a low-cost way to help distinguish legitimate medications from… read more.
Fake news can be tricky to spot, but spotting fake drugs just got a little easier. Researchers have devised a low-cost way to help distinguish legitimate medications from… read more.
NICE(UK): Molnupiravir is recommended as an option for treating mild to moderate COVID‑19 in adults who have a positive SARS‑CoV‑2 test, only if: i) they have 1 or… read more.
The latest, most comprehensive data on the scale of drink spiking in the UK will be presented to the public for the first time at Anglia Ruskin University… read more.
When patients undergo general anesthesia, doctors can choose among several drugs. Although each of these drugs acts on neurons in different ways, they all lead to the same… read more.
LivaNova PLC announced the FDA granted premarket approval (PMA) for the aura 6000 System for the treatment of adult patients with moderate to severe Obstructive Sleep Apnea (OSA)…. read more.
Heart disease is the leading cause of adult death worldwide, making cardiovascular disease diagnosis and management a global health priority. An echocardiogram, or cardiac ultrasound, is one of the most commonly used imaging tools employed by… read more.
A new University of Missouri study suggests mental health policies can play a significant role in how Americans choose political candidates. Past scholarly research has found that most… read more.
Novartis will present data from more than 20 abstracts from its growing immunology portfolio at this year’s American Academy of Dermatology (AAD) Annual Meeting. Presentations include new Rhapsido® (remibrutinib)… read more.
The European Commission has approved a new 7.2 mg once‑weekly maintenance dose of Wegovy (semaglutide injection) for adults living with obesity. This gives doctors another option to help… read more.
Panic buying doesn’t just respond to shortages – it creates them. And according to a University of the Sunshine Coast behavioural scientist, the lessons learned during COVID-19 remain critical for preventing future… read more.
A one-size-fits-all approach to prediabetes treatment may miss the opportunity to implement an early, more intensive, tailored prevention approach for those with the highest risk of developing Type… read more.
Celltrion Inc. announced that Avtozma (tocilizumab-anoh) subcutaneous (SC) formulation is now available to patients in the United States. With this launch, Celltrion’s Avtozma becomes one of the first tocilizumab… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.